Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Operating Margin (2021 - 2025)

Historic Operating Margin for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to 1.96%.

  • Mirum Pharmaceuticals' Operating Margin rose 159900.0% to 1.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.86%, marking a year-over-year increase of 224000.0%. This contributed to the annual value of 26.0% for FY2024, which is 325600.0% up from last year.
  • According to the latest figures from Q3 2025, Mirum Pharmaceuticals' Operating Margin is 1.96%, which was up 159900.0% from 3.9% recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Operating Margin ranged from a high of 1.96% in Q3 2025 and a low of 1452.36% during Q4 2021
  • Over the past 5 years, Mirum Pharmaceuticals' median Operating Margin value was 58.71% (recorded in 2023), while the average stood at 208.53%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 13299400bps in 2022, then skyrocketed by 159900bps in 2025.
  • Mirum Pharmaceuticals' Operating Margin (Quarter) stood at 1452.36% in 2021, then skyrocketed by 92bps to 122.41% in 2022, then soared by 62bps to 46.85% in 2023, then skyrocketed by 48bps to 24.36% in 2024, then skyrocketed by 108bps to 1.96% in 2025.
  • Its last three reported values are 1.96% in Q3 2025, 3.9% for Q2 2025, and 13.61% during Q1 2025.